Almirall, S.A. (ALM.MC)
EUR 8.31
(1.03%)
EUR 8.31
(1.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.37 Billion EUR | 10.58% |
| 2022 | 2.14 Billion EUR | 0.28% |
| 2021 | 2.14 Billion EUR | -6.52% |
| 2020 | 2.29 Billion EUR | -6.09% |
| 2019 | 2.43 Billion EUR | 2.1% |
| 2018 | 2.38 Billion EUR | 9.79% |
| 2017 | 2.17 Billion EUR | -22.78% |
| 2016 | 2.81 Billion EUR | 11.3% |
| 2015 | 2.53 Billion EUR | -0.32% |
| 2014 | 2.54 Billion EUR | 43.31% |
| 2013 | 1.77 Billion EUR | 30.72% |
| 2012 | 1.35 Billion EUR | -6.9% |
| 2011 | 1.45 Billion EUR | -5.21% |
| 2010 | 1.53 Billion EUR | 3.62% |
| 2009 | 1.48 Billion EUR | 6.2% |
| 2008 | 1.39 Billion EUR | -2.97% |
| 2007 | 1.43 Billion EUR | 29.16% |
| 2006 | 1.11 Billion EUR | -7.34% |
| 2005 | 1.2 Billion EUR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 2.3 Billion EUR | -2.85% |
| 2024 Q2 | 2.32 Billion EUR | 0.61% |
| 2023 Q2 | 2.33 Billion EUR | 10.16% |
| 2023 FY | 2.37 Billion EUR | 10.58% |
| 2023 Q1 | 2.12 Billion EUR | -1.1% |
| 2023 Q3 | 2.35 Billion EUR | 0.49% |
| 2023 Q4 | 2.37 Billion EUR | 1.0% |
| 2022 Q2 | 2.14 Billion EUR | 0.0% |
| 2022 FY | 2.14 Billion EUR | 0.28% |
| 2022 Q4 | 2.14 Billion EUR | 0.0% |
| 2021 Q4 | 2.14 Billion EUR | -9.47% |
| 2021 Q2 | 2.19 Billion EUR | -6.14% |
| 2021 FY | 2.14 Billion EUR | -6.52% |
| 2021 Q1 | 2.33 Billion EUR | 2.0% |
| 2021 Q3 | 2.36 Billion EUR | 7.85% |
| 2020 Q1 | 2.38 Billion EUR | -2.38% |
| 2020 Q2 | 2.32 Billion EUR | -2.49% |
| 2020 FY | 2.29 Billion EUR | -6.09% |
| 2020 Q4 | 2.29 Billion EUR | 0.29% |
| 2020 Q3 | 2.28 Billion EUR | -1.63% |
| 2019 Q2 | 2.51 Billion EUR | 1.9% |
| 2019 FY | 2.43 Billion EUR | 2.1% |
| 2019 Q1 | 2.46 Billion EUR | 3.16% |
| 2019 Q3 | 2.5 Billion EUR | -0.47% |
| 2019 Q4 | 2.43 Billion EUR | -2.41% |
| 2018 FY | 2.38 Billion EUR | 9.79% |
| 2018 Q2 | 1.95 Billion EUR | -2.88% |
| 2018 Q3 | 2.42 Billion EUR | 23.6% |
| 2018 Q1 | 2.01 Billion EUR | -7.28% |
| 2018 Q4 | 2.38 Billion EUR | -1.36% |
| 2017 Q3 | 2.24 Billion EUR | -4.75% |
| 2017 Q4 | 2.17 Billion EUR | -3.23% |
| 2017 Q2 | 2.36 Billion EUR | -15.09% |
| 2017 Q1 | 2.78 Billion EUR | -1.33% |
| 2017 FY | 2.17 Billion EUR | -22.78% |
| 2016 Q1 | 2.67 Billion EUR | 5.69% |
| 2016 FY | 2.81 Billion EUR | 11.3% |
| 2016 Q3 | 2.79 Billion EUR | 5.02% |
| 2016 Q4 | 2.81 Billion EUR | 0.69% |
| 2016 Q2 | 2.66 Billion EUR | -0.42% |
| 2015 Q1 | 2.56 Billion EUR | 0.83% |
| 2015 Q3 | 2.49 Billion EUR | -0.21% |
| 2015 Q4 | 2.53 Billion EUR | 1.56% |
| 2015 FY | 2.53 Billion EUR | -0.32% |
| 2015 Q2 | 2.49 Billion EUR | -2.45% |
| 2014 Q4 | 2.54 Billion EUR | 40.7% |
| 2014 FY | 2.54 Billion EUR | 43.31% |
| 2014 Q2 | 1.79 Billion EUR | 0.66% |
| 2014 Q1 | 1.78 Billion EUR | 0.84% |
| 2014 Q3 | 1.8 Billion EUR | 0.35% |
| 2013 Q2 | 1.33 Billion EUR | 0.05% |
| 2013 Q3 | 1.34 Billion EUR | 0.58% |
| 2013 Q4 | 1.77 Billion EUR | 32.27% |
| 2013 FY | 1.77 Billion EUR | 30.72% |
| 2013 Q1 | 1.33 Billion EUR | -1.8% |
| 2012 Q3 | 1.4 Billion EUR | 2.31% |
| 2012 Q4 | 1.35 Billion EUR | -3.33% |
| 2012 FY | 1.35 Billion EUR | -6.9% |
| 2012 Q1 | 1.44 Billion EUR | -0.81% |
| 2012 Q2 | 1.37 Billion EUR | -5.09% |
| 2011 Q2 | 1.54 Billion EUR | 0.92% |
| 2011 Q3 | 1.52 Billion EUR | -1.24% |
| 2011 Q4 | 1.45 Billion EUR | -4.42% |
| 2011 FY | 1.45 Billion EUR | -5.21% |
| 2011 Q1 | 1.52 Billion EUR | -0.49% |
| 2010 Q1 | 1.47 Billion EUR | -0.58% |
| 2010 Q4 | 1.53 Billion EUR | 2.3% |
| 2010 FY | 1.53 Billion EUR | 3.62% |
| 2010 Q3 | 1.5 Billion EUR | 2.86% |
| 2010 Q2 | 1.46 Billion EUR | -0.96% |
| 2009 FY | 1.48 Billion EUR | 6.2% |
| 2009 Q4 | 1.48 Billion EUR | 0.0% |
| 2008 FY | 1.39 Billion EUR | -2.97% |
| 2007 FY | 1.43 Billion EUR | 29.16% |
| 2006 FY | 1.11 Billion EUR | -7.34% |
| 2005 FY | 1.2 Billion EUR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Faes Farma, S.A. | 776.02 Million EUR | -206.043% |
| Laboratorio Reig Jofre, S.A. | 332.44 Million EUR | -614.402% |